-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KqFQIW/6dDqt9cRw9qd0ZGl2QixOXiPrJRDnUmqFSNB6+c/v+BRY27jm6dGItTU/ BP83dGgkNrve/Y7FvSvwjQ== 0000898432-08-001075.txt : 20081023 0000898432-08-001075.hdr.sgml : 20081023 20081023101314 ACCESSION NUMBER: 0000898432-08-001075 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081021 FILED AS OF DATE: 20081023 DATE AS OF CHANGE: 20081023 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACOPEIA INC CENTRAL INDEX KEY: 0001273013 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 510418085 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: P.O. BOX 5350 CITY: PRINCETON STATE: NJ ZIP: 08543-5350 BUSINESS PHONE: 609-452-3600 MAIL ADDRESS: STREET 1: P.O. BOX 5350 CITY: PRINCETON STATE: NJ ZIP: 08543-5350 FORMER COMPANY: FORMER CONFORMED NAME: PHARMACOPEIA DRUG DISCOVERY INC DATE OF NAME CHANGE: 20031212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIOTECHNOLOGY VALUE FUND L P CENTRAL INDEX KEY: 0000918923 STANDARD INDUSTRIAL CLASSIFICATION: INVESTMENT ADVICE [6282] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50523 FILM NUMBER: 081136441 BUSINESS ADDRESS: STREET 1: 900 N. MICHIGAN AVENUE, SUITE 1100 CITY: CHICAGO STATE: IL ZIP: 60611 BUSINESS PHONE: 3125066500 MAIL ADDRESS: STREET 1: 900 N. MICHIGAN AVENUE, SUITE 1100 CITY: CHICAGO STATE: IL ZIP: 60611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BVF PARTNERS L P/IL CENTRAL INDEX KEY: 0001055947 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50523 FILM NUMBER: 081136442 BUSINESS ADDRESS: STREET 1: ONE SANSOME ST STREET 2: 39TH FL CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 3125066500 MAIL ADDRESS: STREET 1: 900 N. MICHIGAN AVENUE STREET 2: SUITE 1100 CITY: CHICAGO STATE: IL ZIP: 60611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BVF INC/IL CENTRAL INDEX KEY: 0001056807 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50523 FILM NUMBER: 081136438 BUSINESS ADDRESS: STREET 1: ONE SANSOME ST STREET 2: 39TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 3125066500 MAIL ADDRESS: STREET 1: C/O GROSVENOR CAPITAL MANAGEMENT STREET 2: 900 N. MICHIGAN AVENUE, SUITE 1100 CITY: CHICAGO STATE: IL ZIP: 60611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIOTECHNOLOGY VALUE FUND II LP CENTRAL INDEX KEY: 0001102444 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50523 FILM NUMBER: 081136440 BUSINESS ADDRESS: STREET 1: ONE SANSOME ST STREET 2: 39TH FL. CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 3125066500 MAIL ADDRESS: STREET 1: C/O GROSVENOR CAPITAL MANAGEMENT STREET 2: 900 N. MICHIGAN AVENUE, SUITE 1100 CITY: CHICAGO STATE: IL ZIP: 60611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BVF INVESTMENTS LLC CENTRAL INDEX KEY: 0001132245 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50523 FILM NUMBER: 081136439 BUSINESS ADDRESS: STREET 1: ONE SANSOME ST. 39TH FL CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 3125066500 MAIL ADDRESS: STREET 1: C/O GROSVENOR CAPITAL MANAGEMENT LP STREET 2: 900 N. MICHIGAN AVENUE, SUITE 1100 CITY: CHICAGO STATE: IL ZIP: 60611 3 1 form3_ex.xml X0203 3 2008-10-21 0 0001273013 PHARMACOPEIA INC PCOP 0001055947 BVF PARTNERS L P/IL 900 N. MICHIGAN AVENUE SUITE 1100 CHICAGO IL 60611 0 0 1 1 Indirect Beneficial Owners 0000918923 BIOTECHNOLOGY VALUE FUND L P 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 0 0 1 1 Indirect Beneficial Owners 0001102444 BIOTECHNOLOGY VALUE FUND II LP C/O GROSVENOR CAPITAL MANAGEMENT 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 0 0 1 1 Indirect Beneficial Owners 0001132245 BVF INVESTMENTS LLC C/O GROSVENOR CAPITAL MANAGEMENT LP 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 0 0 1 1 Indirect Beneficial Owners 0001056807 BVF INC/IL C/O GROSVENOR CAPITAL MANAGEMENT 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 0 0 1 1 Indirect Beneficial Owners Common Stock 831339 D Common Stock 569500 D Common Stock 1999000 D Common Stock 3399839 I See footnotes Common Stock 3399839 I See footnotes Warrants (right to purchase Common Stock) 5.14 2008-10-21 2011-04-19 Common Stock, par value, 0.01 per share 31200 D Warrants (right to purchase Common Stock) 5.14 2008-10-21 2011-04-19 Common Stock, par value, 0.01 per share 21500 D Warrants (right to purchase Common Stock) 5.14 2008-10-21 2011-04-19 Common Stock, par value 0.01 per share 83000 D Warrants (right to purchase Common Stock) 5.14 2008-10-21 2011-04-19 Common Stock, par value, 0.01 per share 135700 I See footnotes 4 and 6 Warrants (right to purchase Common Stock) 5.14 2008-10-21 2011-04-19 Common Stock, par value 0.01 per share 135700 I See footnotes 5 and 6 The shares of Common Stock, Warrants and the shares of Common Stock underlying the Common Stock and Warrants, as applicable, are directly beneficially owned by Biotechnology Value Fund, L.P. ("BVF"), a Delaware limited partnership. The shares of Common Stock, Warrants and the shares of Common Stock underlying the Common Stock and Warrants, as applicable, are directly beneficially owned by Biotechnology Value Fund, II L.P. ("BVF2"), a Delaware limited partnership. The shares of Common Stock, Warrants and the shares of Common Stock underlying the Common Stock and Warrants, as applicable, are directly beneficially owned by BVF Investments, LLC ("BVLLC"), a Delaware limited liability company. The shares of Common Stock, Warrants and the shares of Common Stock underlying the Common Stock and Warrants, as applicable, are indirectly beneficially owned by BVF Partners, L.P., a Delaware limited partnership ("Partners"). Partners is the general partner of BVF and BVF2 and is the manager of BVLLC. The shares of Common Stock, Warrants and the shares of Common Stock underlying the Common Stock and Warrants, as applicable, are indirectly beneficially owned by BVF Inc., a Delaware corporation ("BVF Inc."), which is the general partner of Partners and is also an investment advisor to Partners. Pursuant to the operating agreement of BVLLC, Partners is authorized, among other things to invest funds of Ziff Asset Management, L.P., the majority member fo BVLLC, in the shares of Common Stock described herein and to vote and exercise dispositive power over those securities. Mark N. Lampert is the sole shareholder and sole director of BVF Inc., and is an officer of BVF Inc. This joint filing on Form 3 shall not be deemed an admission that Mark N. Lampert is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any securities covered by this joint filing. Mr. Lampert disclaims beneficial ownership of all securities reported in this joint filing on Form 3, except to the extent that he has a pecuniary interest therein. BVF PARTNERS L.P., By: BVF Inc., its General Partner, By: /s/ Mark N. Lampert, President 2008-10-22 BIOTECHNOLOGY VALUE FUND, L.P., By: BVF Partners L.P., its General Partner, By: BVF Inc., its General Partner, By: /s/ Mark N. Lampert, President 2008-10-22 BIOTECHNOLOGY VALUE FUND II, L.P., By: BVF Partners L.P., its General Partner, By: BVF Inc., its General Partner, By: /s/ Mark N. Lampert, President 2008-10-22 BVF INVESTMENTS, L.L.C., By: BVF Partners, L.P., its Manager, By: BVF Inc., its General Partner, By: /s/ Mark N. Lampert, President 2008-10-22 BVF INC., By: /s/ Mark N. Lampert, President 2008-10-22 -----END PRIVACY-ENHANCED MESSAGE-----